TB-500 Research Endurance Considerations — Comparison
Primary Mechanism Angiogenesis via actin sequestration; promotes capillary density and tissue repair Increases red blood cell production; elevates oxygen-carrying capacity Enhances mitochondrial biogenesis and oxidative phosphorylation efficiency TB-500 builds
This comparison does not assign a generated winner or score.
- Primary Mechanism
- Angiogenesis via actin sequestration; promotes capillary density and tissue repair
- Increases red blood cell production; elevates oxygen-carrying capacity
- Enhances mitochondrial biogenesis and oxidative phosphorylation efficiency
- TB-500 builds vascular infrastructure; EPO increases oxygen transport; MOTS-c optimises cellular energy production. Different mechanisms, different timelines
- Timeline to Measurable Effect
- 21–28 days for structural changes; 5–8 weeks for performance gains
- 2–4 weeks for RBC elevation; immediate haematocrit increase
- 2–3 weeks for mitochondrial density markers; 4–6 weeks for aerobic capacity change
- TB-500 is the slowest to produce functional outcomes but targets foundational vascular capacity
- Dose Frequency Requirement
- Twice weekly for sustained tissue presence (plasma half-life ~10 hours)
- Once weekly; longer half-life (6–8 hours in circulation but sustained effect via bone marrow stimulation)
- Daily or every-other-day; short half-life (~30 minutes in plasma)
- TB-500 requires consistent administration but less frequent than mitochondrial peptides
- Performance Metric Most Affected
- Time-to-exhaustion in sustained aerobic work; improved recovery between high-volume sessions
- VO2 max elevation; increased oxygen delivery at maximal intensity
- Lactate threshold improvement; enhanced fat oxidation at submaximal intensities
- Each targets a different physiological bottleneck. TB-500 addresses tissue-level oxygen perfusion, not systemic transport or metabolic efficiency
- Training Dependency
- Requires concurrent training stress to direct vascular growth; minimal effect in sedentary subjects
- Independent of training. RBC production occurs regardless of activity level
- Moderate training dependency; effect amplified by mitochondrial stress signals from exercise
- TB-500 is the most training-dependent. It amplifies adaptation, it doesn't create it
- TB-500 research endurance considerations differ fundamentally from other endurance-related compounds because the mechanism operates at the tissue structure level, not the metabolic or haematologic level. Comparing TB-500 to EPO is comparing infrastructure expansion to resource availability. Both can improve endurance, but through entirely separate pathways.